Professor of Pediatrics (School of Medicine)
Children with phenylketonuria (a hereditary metabolic disease) represent another population of particular interest to White. The primary emphasis across pediatric populations is the development of executive abilities such as working memory, inhibitory control, and strategic processing. Neuroimaging correlates of cognition are examined using methods such as magnetic resonance imaging and diffusion tensor imaging. The effects of medical interventions on brain and cognition are also examined, such as hydroxyurea and blood transfusion for stroke prevention in children with sickle cell disease and sapropterin dihydrochloride for the treatment of phenylketonuria.
White is also Director of the Developmental & Behavioral Assessment Unit of the Washington University Intellectual and Developmental Disabilities Research Center. This unit provides behavioral consultation and assessment services (e.g., assessment of cognitive, social, emotional, and adaptive function) to investigators conducting research with populations of children with or at risk for developmental disabilities (e.g., autism, fragile X syndrome, premature birth, stroke, traumatic brain injury).